Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report


Genetic factors as predictor of the individual outcome of drug therapy is one aim of personalized medicine approaches. We report a drug metabolism based analysis of genetic polymorphisms in a Caucasian patient receiving fluvastatin and telmisartan experiencing myotoxicity (myalgia and moderate creatine kinase elevation). The obtained findings suggest that… (More)
DOI: 10.1186/1756-0500-7-688


4 Figures and Tables